These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9147754)

  • 1. [Treatment of autoimmune neuromuscular diseases with intravenous immunoglobulins].
    Illa I; Serrano C; Prat C
    Rev Neurol; 1997 Feb; 25(138):263-6. PubMed ID: 9147754
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous immune globulin in neuromuscular disorders.
    Gupta S
    West J Med; 1997 Nov; 167(5):349-50. PubMed ID: 9392991
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile.
    Dalakas MC
    Pharmacol Ther; 2004 Jun; 102(3):177-93. PubMed ID: 15246245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of intravenous immunglobulin in the treatment of autoimmune neuromuscular diseases].
    Molnár MJ
    Ideggyogy Sz; 2006 Mar; 59(3-4):98-106. PubMed ID: 16634454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vesicular and bullous eczema in response to intravenous immunoglobulins (IVIG).
    Maetzke J; Sperfeld AD; Scharffetter-Kochanek K; Sunderkötter C
    Allergy; 2006 Jan; 61(1):145-6. PubMed ID: 16364173
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of intravenous immunoglobulins in the treatment of neuromuscular disorders.
    Voltz R; Hohlfeld R
    Curr Opin Neurol; 1996 Oct; 9(5):360-6. PubMed ID: 8894412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical applications of immunoglobulin in neuromuscular diseases: focus on inflammatory myopathies.
    Souza PV; Pinto WB; Oliveira AS
    Arq Neuropsiquiatr; 2014 Dec; 72(12):966-71. PubMed ID: 25465778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin and quality of life.
    Padua L; Aprile I; Caliandro P; Pazzaglia C; Tonali P
    JAMA; 2004 Sep; 292(12):1429; author reply 1429-30. PubMed ID: 15383509
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid infusion of intravenous immunoglobulin in patients with neuromuscular diseases.
    Gomperts ED; Darr F
    Neurology; 2002 May; 58(9):1444. PubMed ID: 12011310
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuromuscular disease: IVIg for neuromuscular disease-effective but expensive.
    Hughes RA; Lunn MP
    Nat Rev Neurol; 2012 May; 8(6):303-5. PubMed ID: 22614848
    [No Abstract]   [Full Text] [Related]  

  • 11. Complications of intravenous gammaglobulin in neuromuscular and other diseases.
    Bertorini TE; Nance AM; Horner LH; Greene W; Gelfand MS; Jaster JH
    Muscle Nerve; 1996 Mar; 19(3):388-91. PubMed ID: 8606709
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of autoimmune disease: synergy between plasma exchange and intravenous immunoglobulins.
    Nydegger UE; Sturzenegger T
    Ther Apher; 2001 Jun; 5(3):186-92. PubMed ID: 11467755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of chronic autoimmune urticaria using polyvalent immunoglobulins].
    Lacour JP; Machet L; Jullien D; Chosidow O; Mathelier-Fusade P; Guillet G; Humbert P; Doutre MS; Meynadier J
    Ann Dermatol Venereol; 1998 Sep; 125(9):641-4. PubMed ID: 9805560
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
    Sapir T; Blank M; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases.
    Rütter A; Luger TA
    Curr Opin Investig Drugs; 2002 May; 3(5):713-9. PubMed ID: 12090544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro inhibition of antiplatelet autoantibodies by intravenous immunoglobulins and Rh immunoglobulins.
    Mehta YS; Badakere SS
    J Postgrad Med; 1996; 42(2):46-9. PubMed ID: 9715299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with intravenous immunoglobulin in neurological diseases. A descriptive study of effects seen from the patient's and health services' perspectives].
    Wintzell A; Eriksson T; Lundgren A; Petersson J
    Lakartidningen; 2008 May 21-27; 105(21):1571-5. PubMed ID: 18574994
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis].
    Cherin P
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S48-50. PubMed ID: 10896990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin treatment in autoimmune neurological disorders--effects on quality of life.
    Padua L; Sabatelli M; Evoli A; Pazzaglia C; Tonali P
    Hum Immunol; 2005 Apr; 66(4):417-21. PubMed ID: 15866706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic intravenous immunoglobulins.
    Lemieux R; Bazin R; Néron S
    Mol Immunol; 2005 May; 42(7):839-48. PubMed ID: 15829272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.